Re: her2+ bc cured in mice with gamma secretase inhibitor(already developed vs Alzhei
It didn't mention cure and it said the effect was reversible, but it also described long-term recurrence-free survival.
The gamma-secretase inhibitors are only in AD trials, and in one neoadjuvant her2+ bc trials.
A new paper by Dr. Yarden of Israel seems to imply a combination of herceptin and a gamma secretase inhibitor could stop ADH from progressing to DCIS and to her2+ bc.
More to come.
|